These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 18369695

  • 21. Inhibition of protein kinase C-mediated contraction by Rho kinase inhibitor fasudil in rabbit aorta.
    Shimomura E, Shiraishi M, Iwanaga T, Seto M, Sasaki Y, Ikeda M, Ito K.
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Nov; 370(5):414-22. PubMed ID: 15459803
    [Abstract] [Full Text] [Related]

  • 22. LIMK1 depletion enhances fasudil-dependent inhibition of urethral fibroblast proliferation and migration.
    Liang YC, Li XD, Wu YP, Ke ZB, Liu ZQ, Chen SH, Wei Y, Zheng QS, Xue XY, Xu N.
    J Cell Biochem; 2019 Aug; 120(8):12977-12988. PubMed ID: 30861189
    [Abstract] [Full Text] [Related]

  • 23. Rho-kinase inhibitors decrease TGF-beta-stimulated VEGF synthesis through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
    Kuno M, Takai S, Matsushima-Nishiwaki R, Minamitani C, Mizutani J, Otsuka T, Harada A, Adachi S, Kozawa O, Tokuda H.
    Biochem Pharmacol; 2009 Jan 15; 77(2):196-203. PubMed ID: 18996357
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways.
    Wang N, Guan P, Zhang JP, Li YQ, Chang YZ, Shi ZH, Wang FY, Chu L.
    J Cell Biochem; 2011 Jul 15; 112(7):1920-9. PubMed ID: 21433064
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Inhibition of ocular neovascularization by a novel peptide derived from human placenta growth factor-1.
    Zheng Y, Gu Q, Xu X.
    Acta Ophthalmol; 2012 Nov 15; 90(7):e512-23. PubMed ID: 22994140
    [Abstract] [Full Text] [Related]

  • 30. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M, Nakamura T.
    Cancer Res; 2000 Dec 01; 60(23):6737-43. PubMed ID: 11118060
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Anti-angiogenic actions of the mangosteen polyphenolic xanthone derivative α-mangostin.
    Jittiporn K, Suwanpradid J, Patel C, Rojas M, Thirawarapan S, Moongkarndi P, Suvitayavat W, Caldwell RB.
    Microvasc Res; 2014 May 01; 93():72-9. PubMed ID: 24721607
    [Abstract] [Full Text] [Related]

  • 34. Fasudil hydrochloride, a potent ROCK inhibitor, inhibits corneal neovascularization after alkali burns in mice.
    Zeng P, Pi RB, Li P, Chen RX, Lin LM, He H, Zhou SY.
    Mol Vis; 2015 May 01; 21():688-98. PubMed ID: 26120273
    [Abstract] [Full Text] [Related]

  • 35. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
    Deng L, Li G, Li R, Liu Q, He Q, Zhang J.
    Cancer Biol Ther; 2010 Jun 01; 9(11):875-84. PubMed ID: 20364104
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.